Discussion on the Effect of Introducing Clinical Pharmacists to Guide Clinical Medication in ICU

  • Dalai Wuyun Pharmacy Department of Chifeng Municipal Hospital
DOI: https://doi.org/10.18686/aem.v10i1.186
Keywords: ICU, Clinical Pharmacist, Guidance, Clinical Medication, Effect

Abstract

Objective: to investigate the effect of clinical pharmacists in ICU. Methods: 108 ICU patients from January 2018 to March 2020 were divided into the control group and the observation group, with 54 cases in each group. The control group used the previous medication route, while the observation group introduced clinical pharmacists to guide clinical medication. The infection rate and adverse reaction rate of the two groups were compared. Results: the infection rate of the observation group was 3.70%, and that of the control group was 14.81%, which was significantly lower than that of the control group (P<0.05). The adverse reaction rate of the observation group was 5.56%, and that of the control group was 18.52%, which was significantly lower than that of the control group (P<0.05). Conclusion: the introduction of clinical pharmacists to guide clinical medication in ICU can effectively control the infection, and reduce various adverse reactions during drug use, so as to realize the scientific and standardized use of drugs, and improve the efficiency and safety of drug use.

References

[1] Liao Y, Li F, Yan J, et al. The role of clinical phar-macists in the anti-infective treatment of ICU pa-tients with septic shock. Chinese pharmacy 2020; 31(11): 1382–1386.

[2] Chen X, Zhang J. Analysis of clinical pharmacists’ intervention on 156 inpatient orders in ICU.Chinese pharmacy 2014; 25(22): 2031–2034.

[3] Shi Y. Practice and experience of clinical pharma-cists participating in pharmaceutical care for ICU patients with severe infection. Chinese pharmacy 2012; 23(26): 2494–2496.

[4] Zhao N, Shi Y, Liu G, et al. Experience of clinical pharmacist participating in the treatment of one case of acute ivermectin poisoning. Journal of clin-ical drug therapy 2018; 16(9): 90–92.

[5] Wang H, Zhang K, Liu N, et al. Identification and pharmaceutical intervention of potential drug inter-actions in ICU by clinical pharmacists. Chinese journal of hospital pharmacy 2018; 38(16): 1747–1749, 1758.

[6] Liu Y, Che X, Gan L, et al. Construction and ex-ploration of clinical pharmacist training mode of traditional Chinese medicine guided by critical care medicine department. Chinese journal of hospital pharmacy 2019; 39(13): 1317–1321.

[7] Li J, Zhu D. Clinical pharmacists involved in a case of ectopic ACTH syndrome complicated with As-pergillus fumigatus infection. Journal of medical forum 2020; 41(6): 64–67.
Published
2021-04-30
Issue
Vol 10 No 1 (2021)
Section
Original Research Article

Copyright (c) 2021 Dalai Wuyun

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

Authors submitting to USP journals agree to publish their manuscript under the Creative Commons Attribution-NonCommercial 4.0 International License (CC BY-NC 4.0) where authors agree to allow third parties to share their work (copy, distribute, transmit) and to adapt it, under the condition that the authors are given credit, and that in the event of reuse or distribution, the terms of this license are made clear

Authors retain copyright of their work, with first publication rights (online and print) granted to Universe Scientific Publishing or the owner of the journal in question.